Vipanpreet Chahil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vipanpreet Chahil has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Dinesh Kumar Kalra
University of Louisville
3 shared publications Ahtisham Shakoor
Chandler Regional Medical Center, Chandler, AZ, USA (Shakoor)
1 shared publication- Amrit Kahlon
Department of Cardiology, University of Louisville, Louisville, KY 40202, USA
1 shared publication - Ayman Battisha
University of Massachusetts Medical School-Baystate, Springfield, MA. United States
1 shared publication - Dakshinkumaar Devanand
Department of Cardiology, University of Louisville, Louisville, KY 40202, USA
1 shared publication - Ikechukwu Ogbu
Division of Cardiology, Department of Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA
1 shared publication
Latest Publications
- 6 November 2025
- Published by Elsevier in Journal of Clinical Lipidology
Inflammation and cardiometabolic disease in South Asians: The fire and fire tenders
- 6 November 2025
- Published by Elsevier in Journal of Clinical Lipidology
Inflammation and cardiometabolic disease in South Asians: The fire and fire tenders
- Open Access
- 1 September 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (9) , 1968
Postoperative Atrial Fibrillation: A Review
Atrial fibrillation (AF) in the postoperative phase is a manifestation of numerous factors, including surgical stress, anesthetic effects, and underlying cardiovascular conditions. The resultant cardiac hyperactivity can induce new onset or exacerbate existing AF. A common phenomenon, postoperative atrial fibrillation (POAF) affects nearly 40% of patients and is associated with longer hospitalization stays, and increased mortality, heart failure, stroke, and healthcare costs. Areas of controversy in POAF include whether to anticoagulate patients who have short-lived POAF, especially given their higher bleeding risk in the postoperative period, and the identification of patients who would benefit the most from preventive drug therapy for POAF. This review discusses the pathophysiology and management of POAF, and strategies to reduce its occurrence.
- 1 September 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (9) , 1968
Open AccessPostoperative Atrial Fibrillation: A Review
Atrial fibrillation (AF) in the postoperative phase is a manifestation of numerous factors, including surgical stress, anesthetic effects, and underlying cardiovascular conditions. The resultant cardiac hyperactivity can induce new onset or exacerbate existing AF. A common phenomenon, postoperative atrial fibrillation (POAF) affects nearly 40% of patients and is associated with longer hospitalization stays, and increased mortality, heart failure, stroke, and healthcare costs. Areas of controversy in POAF include whether to anticoagulate patients who have short-lived POAF, especially given their higher bleeding risk in the postoperative period, and the identification of patients who would benefit the most from preventive drug therapy for POAF. This review discusses the pathophysiology and management of POAF, and strategies to reduce its occurrence.
- Open Access
- 23 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5001
Sleep Disordered Breathing and Neurocognitive Disorders
Sleep-disordered breathing (SDB), which includes conditions such as obstructive sleep apnea (OSA) and central sleep apnea (CSA), is an independent risk factor for cerebral small vessel disease (CSVD), stroke, heart failure, arrhythmias, and other cardiovascular disorders. The influence of OSA on brain structure and cognitive function has become an essential focus in the heart-brain axis, given its potential role in developing neurocognitive abnormalities. In this review, we found that OSA plays a significant role in the cardio-neural pathway that leads to the development of cerebral small vessel disease and neurocognitive decline. Although data is still limited on this topic, understanding the critical role of OSA in the heart-brain axis could lead to the utilization of imaging modalities to simultaneously identify early signs of pathology in both organ systems based on the known OSA-driven pathological pathways that result in a disease state in both the cardiovascular and cerebrovascular systems. This narrative review aims to summarize the current link between OSA and neurocognitive disorders, cardio-neural pathophysiology, and the treatment options available for patients with OSA-related neurocognitive disorders.
- 23 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 5001
Open AccessSleep Disordered Breathing and Neurocognitive Disorders
Sleep-disordered breathing (SDB), which includes conditions such as obstructive sleep apnea (OSA) and central sleep apnea (CSA), is an independent risk factor for cerebral small vessel disease (CSVD), stroke, heart failure, arrhythmias, and other cardiovascular disorders. The influence of OSA on brain structure and cognitive function has become an essential focus in the heart-brain axis, given its potential role in developing neurocognitive abnormalities. In this review, we found that OSA plays a significant role in the cardio-neural pathway that leads to the development of cerebral small vessel disease and neurocognitive decline. Although data is still limited on this topic, understanding the critical role of OSA in the heart-brain axis could lead to the utilization of imaging modalities to simultaneously identify early signs of pathology in both organ systems based on the known OSA-driven pathological pathways that result in a disease state in both the cardiovascular and cerebrovascular systems. This narrative review aims to summarize the current link between OSA and neurocognitive disorders, cardio-neural pathophysiology, and the treatment options available for patients with OSA-related neurocognitive disorders.